ENDODAN (STAT RX USA LLC)


Welcome to the PulseAid listing for the ENDODAN drug offered from STAT RX USA LLC. This Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: STAT RX USA LLC
NON-PROPRIETARY NAME: OXYCODONE and ASPIRIN
SUBSTANCE NAME: OXYCODONE HYDROCHLORIDE; ASPIRIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 1994-05-20
END MARKETING DATE: 0000-00-00


ENDODAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionENDODAN from STAT RX USA LLC
LABELER NAME: STAT RX USA LLC
DEA SCHEDULE: CII
ACTIVE STRENGTH: 4.8355; 325(mg/1; mg/1)
START MARKETING DATE: 1994-05-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 16590-947_4f2f4e43-bf7a-498a-9367-e0bdaf0cf8da
PRODUCT NDC: 16590-947
APPLICATION NUMBER: NDA007337

Other OXYCODONE HYDROCHLORIDE; ASPIRIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Oxycodone and Aspirin
Mayne Pharma Inc.Oxycodone and Aspirin
STAT RX USA LLCENDODAN